Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. CSPC Pharmaceutical Group (SEHK:1093) has received ...

Detailed price information for Cspc Pharm Group Ltd Ord (CHJTF) from The Globe and Mail including charting and trades.

In business as in medicine, a remedy can take time to kick in. This is the challenge for Chinese drug giant CSPC Pharmaceutical Group Ltd. (1093.HK), which is trying to transform itself from being a ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

The latest announcement is out from CSPC Pharmaceutical Group ( (HK:1093)). CSPC Pharmaceutical Group announced that its subsidiary’s Phase Ib/III study of Sirolimus for Injection (Albumin‑bound), ...

Chinese companies in the drug discovery business have been haunted by a strange phenomenon for the past few months. After announcing large and lucrative licensing deals, their share prices have ...

CSPC Pharmaceutical Group has received approval from China’s National Medical Products Administration for their Tedizolid Phosphate Tablets. This novel antibiotic is designed to treat acute bacterial ...

Verastem Oncology to Receive an Upfront Payment of $15 Million USD; Then Eligible to Receive Up To $30 Million USD in Development Milestone Payments as well as Sales Milestone and Double-Digit ...

CSPC operates in a fast-growing and rapidly changing environment. Like most healthcare sectors in China, drug manufacturing has grown faster than GDP, and is projected to continue this trend over the ...

Narrow-moat CSPC’s 01093 interim results fell short of expectations. Revenue for the six months grew 3% year on year whereas operating profit, calculated with cost of sales and expenses for sales, ...